CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on developing a novel platform to study how the gut microbiome affects the response of tumors to immunotherapy. The system integrates patient-derived samples to create personalized models that can predict treatment outcomes and improve cancer therapies.
In 2020, cancer affected 2.7 million people in the European Union and claimed 1.3 million lives, including more than 2,000 young adults.
If immediate action is not taken, cancer cases are expected to increase by 24% by 2035.
This project aims to accelerate the development of new cancer therapies.
Immunotherapy, particularly through immune checkpoint inhibitors (ICIs), stands out as a highly promising treatment, utilizing the body's own immune system to target and destroy cancer cells with greate…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Italy, Milano
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
